Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected1M Return
Partial Period · Jul 31, 2026 — Sep 4, 2026
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | BIIB | ABBV |
|---|---|---|
| Return | ||
| Last Price | 220.90 | 256.46 |
| Daily Change | − 1.61% | − 1.44% |
| Period ReturnPast Month | + 8.42% | + 2.20%Jul 31, 2026 — Sep 4, 2026 |
| Valuation | ||
| Market Cap | $32.6 B | $453 B |
| P/E Ratio | — | 72.05 |
| Dividend Yield | — | 4.47% |
| Net MarginTrailing 12M | — | 9.8% |
| Risk | ||
| Beta | — | 0.20 |
| 52-Week Range | — | 190.75 — $267.47 |
| Company | ||
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
Company
- BIIBHealth Care · Biotechnology
- ABBVHealth Care · Biotechnology
Metrics could not be loaded for BIIB: P/E, dividend, beta and the 52-week range stay empty in that column.
Alpaca · SIPUpdated 02:0015 Minutes Delayed
To Understand This